Kazia Therapeutics logo

Kazia Therapeutics Share Price Today

(NASDAQ: KZIA)

Kazia Therapeutics share price is $0.79 & ₹68.71 as on 6 Mar 2025, 2.30 'hrs' IST

$0.79

0.03

(3.44%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Kazia Therapeutics share price in Dollar and Rupees. Guide to invest in Kazia Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Kazia Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Kazia Therapeutics share price movements

  • Today's Low: $0.76
    Today's High: $0.81

    Day's Volatility :6.17%

  • 52 Weeks Low: $0.76
    52 Weeks High: $15.80

    52 Weeks Volatility :95.22%

Kazia Therapeutics (KZIA) Returns

PeriodKazia Therapeutics LtdIndex (Russel 2000)
3 Months
-82.37%
0.0%
6 Months
-80.73%
0.0%
1 Year
-63.41%
0.0%
3 Years
-98.75%
-11.6%

Kazia Therapeutics (KZIA) Key Statistics

in dollars & INR

Previous Close
$0.7637
Open
$0.81
Today's High
$0.81
Today's Low
$0.76
Market Capitalization
$4.4M
Today's Volume
$86.8K
52 Week High
$15.8
52 Week Low
$0.756
Revenue TTM
$2.5M
EBITDA
$-26.6M
Earnings Per Share (EPS)
$-6.32
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-2634.33%

How to invest in Kazia Therapeutics Stock (KZIA) from India?

It is very easy for Indian residents to invest directly in Kazia Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Kazia Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Kazia Therapeutics or KZIA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Kazia Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Kazia Therapeutics shares which would translate to 1.101 fractional shares of Kazia Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Kazia Therapeutics, in just a few clicks!

Returns in Kazia Therapeutics (KZIA) for Indian investors in Rupees

The Kazia Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Kazia Therapeutics investment value today

Current value as on today

₹41,523

Returns

₹58,477

(-58.48%)

Returns from Kazia Therapeutics Stock

₹63,426 (-63.43%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Kazia Therapeutics (KZIA)

-42%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Kazia Therapeutics Stock from India on INDmoney has decreased by -42% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Kazia Therapeutics

  • Mccormack Advisors International

    2.49%

  • Barclays PLC

    2.15%

  • UBS Group AG

    0.49%

  • Morgan Stanley - Brokerage Accounts

    0.42%

  • JPMorgan Chase & Co

    0.13%

  • Rhumbline Advisers

    0.05%

Analyst Recommendation on Kazia Therapeutics

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Kazia Therapeutics(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
4
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Kazia Therapeutics Stock (KZIA)

What analysts predicted

Upside of 270.95%

Target:

$2.93

Current:

$0.79

Insights on Kazia Therapeutics Stock (Ticker Symbol: KZIA)

  • Price Movement

    In the last 1 month, KZIA stock has moved down by -47.3%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 555.0 → 5.0 (in $), with an average decrease of 99.1% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -3.43M → -8.82M (in $), with an average decrease of 64.1% per quarter
  • KZIA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 129.9%
  • KZIA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 150.4%
  • Price to Sales

    ForKZIA every $1 of sales, investors are willing to pay $0.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Kazia Therapeutics Technicals Summary

Sell

Neutral

Buy

Kazia Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Kazia Therapeutics (KZIA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Kazia Therapeutics Ltd logo
-43.57%
-80.73%
-63.41%
-98.75%
-97.99%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Kazia Therapeutics Ltd logo
NA
NA
NA
-0.05
-26.34
-0.72
NA
-3.01
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Kazia Therapeutics Ltd logo
Buy
$4.4M
-97.99%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Kazia Therapeutics

Kazia Therapeutics Limited, together with its subsidiaries, operates as an oncology-focused biotechnology company in South Korea. Its lead development candidate is paxalisib, a small molecule, brain-penetrant inhibitor of the phosphoinositide-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway, which is in Phase 3 clinical trial, for the treatment of glioblastoma, isocitrate dehydrogenase-mutant glioma, diffuse intrinsic pontine glioma, atypical teratoid/rhabdoid tumor, brain metastases, primary central nervous system (CNS) lymphoma, triple negative breast cancer, and ovarian cancer. The company also develops EVT801, a small-molecule selective inhibitor of vascular endothelial growth factor receptor 3, which is in Phase 1 clinical trial, to treat advanced solid tumors. It has collaborations with the Australian and New Zealand Children's Haematology/Oncology Group, OIMR Berghofer Medical Research Institute, Genentech Inc., Global Coalition for Adaptive Research, Vivesto AB, Simcere Pharmaceutical Group Ltd, Evotec SE, and Sovargen Co., Ltd. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was incorporated in 1994 and is based in Sydney, Australia.
Organization
Kazia Therapeutics
Employees
0
CEO
Dr. John Edwin Friend II, M.D.
Industry
Health Technology

Management People of Kazia Therapeutics

NameTitle
Dr. John Edwin Friend II, M.D.
CEO, MD & Director
Ms. Elissa C. Hansen ACSA, B.Com., B.Comm, FCIS, Gad Dip ACG, GAI, GAIC
Company Secretary
Mr. Jeffrey Bonacorda
VP of Finance & Controller

Important FAQs about investing in KZIA Stock from India :

What is Kazia Therapeutics share price today?

Kazia Therapeutics share price today stands at $0.79, Open: $0.81 ; Previous Close: $0.76 ; High: $0.81 ; Low: $0.76 ; 52 Week High: $15.80 ; 52 Week Low: $0.76.

The stock opens at $0.81, after a previous close of $0.76. The stock reached a daily high of $0.81 and a low of $0.76, with a 52-week high of $15.80 and a 52-week low of $0.76.

Can Indians buy Kazia Therapeutics shares?

Yes, Indians can invest in the Kazia Therapeutics (KZIA) from India.

With INDmoney, you can buy Kazia Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Kazia Therapeutics at zero transaction cost.

How can I buy Kazia Therapeutics shares from India?

It is very easy to buy Kazia Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Kazia Therapeutics (KZIA) be purchased?

Yes, you can buy fractional shares of Kazia Therapeutics with INDmoney app.

What are the documents required to start investing in Kazia Therapeutics stocks?

To start investing in Kazia Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Kazia Therapeutics Stock (KZIA)?

Today’s highest price of Kazia Therapeutics (KZIA) is $0.81.

Today’s lowest price of Kazia Therapeutics (KZIA) is $0.76.

What is today's market capitalisation of Kazia Therapeutics?

Today's market capitalisation of Kazia Therapeutics KZIA is 4.4M

What is the 52 Week High and Low Range of Kazia Therapeutics Stock (KZIA)?

  • 52 Week High

    $15.80

  • 52 Week Low

    $0.76

What are the historical returns of Kazia Therapeutics (KZIA)?

  • 1 Month Returns

    -43.57%

  • 3 Months Returns

    -80.73%

  • 1 Year Returns

    -63.41%

  • 5 Years Returns

    -97.99%

Who is the Chief Executive Officer (CEO) of Kazia Therapeutics ?

Dr. John Edwin Friend II, M.D. is the current Chief Executive Officer (CEO) of Kazia Therapeutics.